|
August 25, 2008: Baxter Announces Licensing Agreement for Innocoll´s Gentamicin Surgical Implant in the United States
July 31, 2008: Children's Memorial Hospital Celebrates Opening of Jeffrey Modell Foundation Diagnostic Center for Primary Immunodeficiencies
July 29, 2008: Baxter Declares Quarterly Dividend
July 17, 2008: Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
June 19, 2008: Baxter Releases Ninth Annual Sustainability Report
June 11, 2008: The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter´s Cell-Based Pandemic, Avian Flu Vaccine
June 06, 2008: Baxter Preclinical Data of Longer-Acting Factor VIII for Hemophilia A Presented at International Congress
June 05, 2008: Baxter Announces Winners of “Picture Your Tomorrow, Today” Global Photo Contest
June 05, 2008: Baxter Highlights Recent Sustainability Achievements and Recognition
May 07, 2008: Professor Sir Michael G. Marmot Selected as 2008 Recipient of the William B. Graham Prize for Health Services Research
May 06, 2008: Baxter's Board of Directors Declares Quarterly Dividend
April 17, 2008: Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
April 17, 2008: Baxter Honors World Hemophilia Day with Donation to World Federation of Hemophilia's Global Alliance for Progress
April 17, 2008: Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
April 15, 2008: Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease
April 09, 2008: Baxter´s V-Link Luer-Activated Device with VitalShield Protective Coating Now Available for Hospitals
March 20, 2008: Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
March 18, 2008: Baxter´s Board of Directors Approves New Share Repurchase Authorization of $2 Billion
March 16, 2008: Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
March 15, 2008: Undiagnosed Primary Immunodeficiency Disorders are Associated with Substantial Healthcare Cost and Resource Use
March 10, 2008: Baxter and its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
February 28, 2008: Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products
February 21, 2008: Baxter Highlights Recent Sustainability Achievements and Recognition
February 12, 2008: Baxter Declares Quarterly Dividend
February 11, 2008: Baxter Provides Update on Heparin Reactions
February 04, 2008: Baxter's Costa Rica Facility Recognized with Shingo Prize for Excellence in Manufacturing
January 25, 2008: Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/ML 10 and 30mL Multi-Dose Vials
January 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
January 10, 2008: Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
January 07, 2008: Baxter Announces Recombinant Factor IX Development Program for Hemophilia B
January 07, 2008: Baxter to Market Nycomed´s TachoSil® in the United States
December 17, 2007: Baxter Announces FDA Approval of GELFOAM® Plus Hemostasis Kit
December 03, 2007: Baxter Introduces New Drug Safety Packaging for High Alert Medications
November 27, 2007: U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC´s DVC and Baxter
|
Print this page
